Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) Peptid
SPG20
Wirt: Synthetic
BP, Imm
-
- Target Alle SPG20 Produkte
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunogen (Imm)
- Sequenz
- EASGTDVKQL DQGNK
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at ambient temperature, store at -20°C.
-
- Target
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- Synonyme
- SPARTIN Peptide, TAHCCP1 Peptide, AI840044 Peptide, C79168 Peptide, mKIAA0610 Peptide, spartin Peptide, Spg20 Peptide, spg20a Peptide, zgc:172059 Peptide, spg20b Peptide, zgc:153766 Peptide, spartin Peptide, spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) Peptide, spartin a Peptide, spartin b Peptide, SPART Peptide, Spg20 Peptide, Spart Peptide, sparta Peptide, spartb Peptide
-
Sie sind hier:
